Advertisement

Freiburg Neuropathology Case Conference

A Progressive Lesion of the Optic Tract, Brainstem, Hypothalamus and Basal Ganglia
  • C. A. TaschnerEmail author
  • S. Doostkam
  • P. C. Reinacher
  • H. Urbach
  • A. Rau
  • M. Prinz
Clinical Case

Case Report

A 63-year-old male patient presented with a 6-month history of reduction in performance and fatigue as well as a change in character and for 3 months he had an additional deterioration in vigilance with an increasing imperative urge to sleep and a frontal disinhibition, which led to admission to psychiatry. Magnetic resonance imaging (MRI) revealed a suspicious lesion of the right optic tract and the hypothalamus (Figs. 1 and 2). A stereotactic biopsy in the area of the right hypothalamus above the optic tract was performed, revealing only small cell groups of B and T cells , which were considered non-specific; however, the patient had been under corticotherapy in the month prior to the biopsy and 2 months later the patient presented in a clinically stable condition and the corticotherapy had been discontinued. On MRI new lesions had occurred (Figs. 3 and 4) located bilaterally in the basal ganglia and a second stereotactic biopsy was performed targeting out...

Notes

Compliance with ethical guidelines

Conflict of interest

C.A. Taschner, S. Doostkam, P.C. Reinacher, H. Urbach, A. Rau and M. Prinz declare that they have no competing interests.

Ethical standards

All investigations described in this manuscript were carried out with the approval of the responsible ethics committee and in accordance with national law and the Helsinki Declaration of 1975 (in its current revised form). Informed consent was obtained from the patient in this case if identifiable from images or other information within the manuscript.

References

  1. 1.
    Hebel R, Dubaniewicz-Wybieralska M, Dubaniewicz A. Overview of neurosarcoidosis: recent advances. J Neurol. 2015;262:258–67.CrossRefGoogle Scholar
  2. 2.
    Ginat DT, Dhillon G, Almast J. Magnetic resonance imaging of neurosarcoidosis. J Clin Imaging Sci. 2011;1:15.CrossRefGoogle Scholar
  3. 3.
    Black DF, Aksamit AJ, Morris JM. MR imaging of central nervous system Whipple disease: a 15-year review. AJNR Am J Neuroradiol. 2010;31:1493–7.CrossRefGoogle Scholar
  4. 4.
    Kerbauy MN, Moraes FY, Lok BH, Ma J, Kerbauy LN, Spratt DE, et al. Challenges and opportunities in primary CNS lymphoma: a systematic review. Radiother Oncol. 2017;122:352–61.CrossRefGoogle Scholar
  5. 5.
    Mansour A, Qandeel M, Abdel-Razeq H, Abu Ali HA. MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging. 2014;14:22.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Williams RL, Meltzer CC, Smirniotopoulos JG, Fukui MB, Inman M. Cerebral MR imaging in intravascular lymphomatosis. AJNR Am J Neuroradiol. 1998;19:427–31.PubMedGoogle Scholar
  7. 7.
    Martin-Duverneuil N, Mokhtari K, Behin A, Lafitte F, Hoang-Xuan K, Chiras J. Intravascular malignant lymphomatosis. Neuroradiology. 2002;44:749–54.CrossRefGoogle Scholar
  8. 8.
    Taschner CA, Süß P, Sajonz B, Urbach H, Simon-Gabriel CP, Prinz M. Freiburg Neuropathology Case Conference : widespread white matter lesions in a patient with progressive paraparesis and cortical blindness. Clin Neuroradiol. 2017;27:245–50.CrossRefGoogle Scholar
  9. 9.
    Taschner CA, Doostkam S, Shah JM, Urbach H, Jäger M, Prinz M. Freiburg Neuropathology Case Conference: cystic posterior fossa tumor. Clin Neuroradiol. 2017;27:393–8.CrossRefGoogle Scholar
  10. 10.
    Schlegel U. Primary CNS lymphoma. Ther Adv Neurol Disord. 2009;2:93–104.CrossRefGoogle Scholar
  11. 11.
    Louis DN, et al. WHO classification of tumours of the central nervous system. 4th ed. 2016.Google Scholar
  12. 12.
    Von Baumgarten L, Illerhaus G, Korfel A, Schlegel U, Deckert M, Dreyling M. The diagnosis and treatment of primary CNS lymphoma—an interdisciplinary challenge. Dtsch Ärztebl Int. 2018;115:419–26.Google Scholar
  13. 13.
    Korfel A, Schlegel U. Diagnosis and treatment of primary CNS lymphoma. Nat Rev Neurol. 2013;9:317–27.CrossRefGoogle Scholar
  14. 14.
    Hoang-Xuan K, Bessell E, Bromberg J, Hottinger AF, Preusser M, Rudà R, et al. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 2015;16:e322–32.CrossRefGoogle Scholar
  15. 15.
    Deckert M, Brunn A, Montesinos-Rongen M, Terreni MR, Ponzoni M. Primary lymphoma of the central nervous system—a diagnostic challenge. Hematol Oncol. 2014;32:57–67.CrossRefGoogle Scholar
  16. 16.
    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–20.CrossRefGoogle Scholar
  17. 17.
    Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985–1999. Neuro Oncol. 2006;8:27–37.CrossRefGoogle Scholar
  18. 18.
    Shiels MS, Pfeiffer RM, Besson C, Clarke CA, Morton LM, Nogueira L, et al. Trends in primary central nervous system lymphoma incidence and survival in the U.S. Br J Haematol. 2016;174:417–24.CrossRefGoogle Scholar
  19. 19.
    Mendez JS, Ostrom QT, Gittleman H, Kruchko C, DeAngelis LM, Barnholtz-Sloan JS, et al. The elderly left behind—changes in survival trends of primary central nervous system lymphoma over the past four decades. Neuro Oncol. 2018;20:687–94.CrossRefGoogle Scholar
  20. 20.
    Deckert M, Engert A, Brück W, Ferreri AJ, Finke J, Illerhaus G, et al. Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia. 2011;25:1797–807.CrossRefGoogle Scholar
  21. 21.
    Brück W  Brunn A, Klapper W, Kuhlmann T, Metz I, Paulus W, et al. Differential diagnosis of lymphoid infiltrates in the central nervous system: experience of the network lymphomas and Lymphomatoid lesions in the nervous system. Pathologe. 2013;34:186–97.CrossRefGoogle Scholar
  22. 22.
    Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, et al. Prognostic scoring system for primary CNS lymphomas: the international extranodal lymphoma study group experience. J Clin Oncol. 2003;21:266–72.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • C. A. Taschner
    • 1
    Email author
  • S. Doostkam
    • 2
  • P. C. Reinacher
    • 3
  • H. Urbach
    • 1
  • A. Rau
    • 1
  • M. Prinz
    • 2
  1. 1.Department of Neuroradiology, Medical CentreUniversity of FreiburgFreiburgGermany
  2. 2.Department of Neuropathology, Medical CentreUniversity of FreiburgFreiburgGermany
  3. 3.Department of Stereotactic and Functional Neurosurgery, Medical CentreUniversity of FreiburgFreiburgGermany

Personalised recommendations